Comparison of Double Disc and Combined Disc Method for the detection of Extended Spectrum β Lactamases in Enterobacteriaceae

Journal of the Pakistan Medical Association

Volumn 53, Issue 11, 2003, Pages 534-536

  Jabeen, K ^a   Zafar, A ^a   Hasan, R ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFIXIME; CEFOTAXIME; CEFUROXIME; CLAVULANIC ACID;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMBINED DISC METHOD; DOUBLE DISC METHOD; ENTEROBACTERIACEAE; ENZYME ASSAY; ENZYME SYNTHESIS; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; TREATMENT FAILURE; VALIDATION PROCESS;

BETA-LACTAMASES; ENTEROBACTERIACEAE; FALSE POSITIVE REACTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PAKISTAN;

EID: 0347719690     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nathisuwan S, Burgess S, Lewis II J. Extended-Spectrum β-Lactamases: epidemiology, detection and treatment. Pharmacotherapy 2001;21:920-8.
2. Knothe H, Krcmery V, Antal M, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-17.
3. Jacoby GA, Medeiros AA, O'Brien TF, et al. Broad-spectrum transmissible β-Lactamases. N Engl J Med 1989;319:723-4.
4. Philippon A, Labia R, Jacoby G. Extended-spectrum β-Lactamases. Antimicrob agents. Chemother 1989;33:1131-6.
5. Nordman P, Guibert M. Extended Spectrum beta Lactamase in Pseudomonas aeruginosa. J Antimicrob Agents Chemother 1998;42:128-31.
6. Cormican MG, Marshall SA, Jones RN. Detection of extended spectrum beta Lactamase producing stram by Etest ESBL screen. J Clin Microb 1996;34:1880-4.
7. Jacoby GA, Mederios AA. More extended spectrum beta Lactamases. Antimicrob Agents Chemother 1991;35:1697-1704.
8. Jacoby GA. Genetics of extended-spectrum β-Lactamases. Eur J Clin Infect Dis 1994;13 (suppl 1):S2-11.
9. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-Lactamase and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
10. Winokur P, Jones RN, Pfaller MA, et al. Characterization of strains from Europe, North and Latin America, and Western Pacific that express an extended-spectrum β-lactamase phenotype: report from the SENTRY antimicrobial surveillance program (1997-1999). Presented at the 40th interscience conference on antimicrobial agents and chemotherapy. Toronto, Canada, September 17-20, 2000.
11. Adedeji A, Vangala K, Saurina G, et al. Molecular epidemiology of Klebsiella pneumoniae with extended-spectrum β-lactamase (ESBLs) in Brooklyn, NY. Presented at the 38th annual meeting of the Infectious Disease Society of America, New Orleans, LA, September 7-10, 2000.
12. Lautenbach E, Patel JB, Bilker WB, et al. Extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact on resistance of outcomes. Clin Infect Dis 2001;32:1162-71.
13. Shah AA, Hasan F, Ahmed S, et al. Extended spectrum beta lactamases in Enterobacteriaceae: related to age and gender. New Microbiol 2002;25:363-6.
14. Zaman G, Karamat AK, Abbasi AS, et al. A prevalence of extended spectrum beta lactamase producing enterobacteriaceae in nosocomial isolates. Pak Armed Forces Med J 1999;49:91-6.
15. Paterson DL, Yu LV. Extended spectrum beta lactamases: a call for improved detection and control. Clin Inf Dis 1999;29:1419-22.
16. Emery CL, Weymouth LA. Detection and clinical significance of extended spectrum beta lactamases in a tertiary care medical center. J Clin Microbiol 1997;35:2061-7.
17. Jacoby GA, Han P. Detection of extended spectrum beta lactamases in clinical isolates of Klebsiella pneumoniae and escherichia coli. J Clin Microbiol 1996;34:908-11.
18. Steward CD, Wallace D, Hubert SK, et al. Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories. Diagn Microbiol Infect Dis 2000;38:59-67.
19. Livermore DM, Yuan M. Antibiotic resistance and production of extended spectrum beta lactamases amongst Klebsiella spp. from ICUs in Europe. J Antmicrob Chemother 1996;38:409-24.
20. Tenover FC, Mohammed MJ, Gorton TS, et al. Detection and reporting of organisms producing extended-spectrum β-Lactamase: survey of laboratories in Connecticut. J Clin Microbiol 1999;37:4065-70.
21. National Committee for Clinical Laboratory Standards. Performance standards for Antimicrobial susceptibility testing. 9th informational supplement ed. Wayne PA: National Committee for Clinical Laboratory Standards 1999.
22. Livermore DM, Brown DFJ. Detection of beta lactamase mediated resistance. J Antimicrob Chemother 2001;48 (suppl):S159-64.
23. Jalier V, Nicholas M, Fournier G, et al. Extended broad-spectrum beta lactamases conferring transferable resistance to newer beta lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
24. Thomson KS, Sanders CC. Detection of extended spectrum beta lactamases in members of family Enterobacteriacea: comparison of double disc and three-dimensional tests. Antimicrob Agents Chemother 1992;36:1877-82.
25. National Committee for Clinical Laboratory Standards. Method for dilutional antimicrobial susceptibility tests for bacteria that grow aerobically. 2000 Approved standard M7-A5 and informational supplement M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. Bradford AP. Extended spectrum beta lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
27. Koneman EW, Allen SD, Janda WM, et al. Color atlas and text book of diagnostic microbiology, 5th ed. Philadelphia: Lippincott, 1977.
28. Lucet JC, Decre D, Fichelle A, et al. Control of a prolonged outbreak of extended spectrum beta lactamase producing enterobacteriaceae in a university hospital. Clin Infect Dis 1999;29:1411-8.
29. M'Zali FH, Chanawong A, Kerr KG, et al. Detection of extended spectrum beta lactamases in members of family Enterobacteriaceae, comparison of the Mast DD test, the double disc and the Etest ESBL. J Antimicrob Chemother 2000;45:881-5.
30. Tenover FC, Mohammad MJ, Stelling J, et al. Ability of laboratories to detect emerging antimicrobial resistance, proficiency testing and quality control results from World Health Organization's external quality assurance system for antimicrobial susceptibility testing. J Clin Microbiol 2001;39:241-50